Library

Project Explore

Explore is a nationwide HIV prevention behavioral trial involving nearly 4,300 men who have sex with men.

Afroamericano/as

¿Qué necesítan los afro-americanos en la prevención del VIH? (revisado 8/00) ¿corren el riesgo de contraer el VIH los afro-americanos? Sí. Muchos Afro-Americanos corren alto riesgo de infectarse con VIH, no por razones étnicas o raciales, sino por los comportamientos de riesgo en los que pueden estar participando.

Deaf persons

What Are Deaf Persons’ HIV Prevention Needs? Are deaf persons at risk for HIV? Yes. It is estimated that 7,000 to 26,000 deaf persons in the US are infected with HIV.1 However, the Centers for Disease Control and Prevention (CDC) does not currently collect information on deafness and HIV or AIDS. Maryland was the first state to include questions about deafness in its HIV counseling and testing forms.

Proveedores de salud

¿Pueden los proveedores de salud ayudar en la prevención del VIH? (revisado 4/99)

Sordos

¿Qué necesítan los sordos en la prevención del VIH? ¿están a riesgo de contraer el VIH? Si. Se estima que en los EEUU existen de 7,000 a 26,000 personas carentes del sentido auditivo infectadas con el VIH.1 Sin embargo, los Centros para el Control de Enfermedades (CDC por sus siglas en Inglés) actualmente no recopilan información acerca de los que padecen de sordera y VIH o SIDA.

What are African-Americans’ HIV prevention needs?

What Are African-Americans’ HIV Prevention Needs? revised 9/99 Are African-Americans at risk for HIV? Yes. Many African-Americans are at high risk for HIV infection, not because of their race or ethnicity, but because of the risk behaviors they may engage in.

Adolescentes

¿Qué necesitan los adolescentes en la prevención del VIH? ¿pueden contraer los adolescentes el VIH? Desafortunadamente, sí. Los casos de infección del VIH se incrementan más aceleradamente en los jóvenes. La mitad de todos los casos de VIH se presentan en personas menores de 25 años. De todos los casos de VIH de 1994-1997 en jóvenes de 13-24 años, 44% eran mujeres y 63% Afro-Americanos.

Adolescents

What Are Adolescents’ HIV Prevention Needs? Can adolescents get HIV? Unfortunately, yes. HIV infection is increasing most rapidly among young people. Half of all new infections in the US occur in people younger than 25. From 1994 to 1997, 44% of all HIV infections among young people aged 13-24 occurred among females, and 63% among African-Americans.

Healthcare workers

Can Healthcare Workers Help in HIV Prevention? revised 4/99 Are healthcare providers important in prevention? Yes. Healthcare providers have many opportunities to help foster the behavior changes needed to stem the spread of HIV infection. In the US in 1996, the average adult visited a physician 3 times a year.

Intercambio de jeringas

¿Sirve el intercambio de jeringas? (revisado 4/99)

Needle exchange programs (NEP)

Does HIV Needle Exchange Work? revised 12/98 Why do we need needle exchange? More than a million people in the US inject drugs frequently, at a cost to society in health care, lost productivity, accidents, and crime of more than $50 billion a year.1 People who inject drugs imperil their own health. If they contract HIV or hepatitis, their needle-sharing partners, sexual partners and offspring may become infected.

Paving the Road to an HIV Vaccine: Employing Tools of Public Policy to Overcome Scientific, Economic, Social and Ethical Obstacles

In June 1996, the Center for AIDS Prevention Studies published the second occasional paper in this monograph series, entitled Sustaining Support for Domestic HIV Vaccine Research: Social Issues Over the Long Haul of Human Trials. Authored by Chris Collins, the research was supported by grants from the National Institute of Mental Health, National Institutes of Health and the University of California, San Francisco. This new report is intended to function as an update to the 1996 monograph.

Home testing

What Is the Role of HIV Testing at Home? Is home HIV testing feasible? Home-access testing for HIV met with virtually unanimous opposition when it was first proposed.1 Today, the Centers for Disease Control (CDC), leading clinicians, gay activists and AIDS advocates have all endorsed home access testing.2 The barriers to home access testing have not been technical, as feasibility studies have demonstrated.3 Home testing has b

Prevención Posexposición

¿Que es la prevención pos-exposición (PEP)? ¿por qué PEP ahora? Aún no se descubre la cura del SIDA. La prevención continúa siendo la mejor forma de detener esta epidemia.

Prueba del VIH en casa

¿Que papel juega hacerse la prueba del VIH en casa? ¿será factible el examen casero para la detección del VIH? Cuando por primera vez se planteó la posibilidad de poner al alcance del público un estuche casero para la detección del VIH, esa se encontró con oposición unánime.1 Hoy en día los Centros para el Control de Enfermedades (CDC, por sus siglas en Inglés), destacados miembros del sector salud, activistas “gay” y los defensores de la lucha contra el SI

Focus Group Questions for Sexual Negotiations

The following two outlines of focus group questions are taken from the Sexual Negotiations among Young Adults in the Era of AIDS research study. Prepared by Diane Binson, PI. Funded by the Universitywide AIDS Research Program, R94-SF-050. Instruments:

Married & Unmarried Latinos

The questionnaires for unmarried Latino women and men were used in a random digit dial telephone survey of 1500 Latinos in ten states in the U.S. These states contain 90% of all Latinos living in the continental U.S. The survey was designed to assess risk for HIV due to sexual behaviors as well as the variables that might predict sexual behaviors such as condom use.

Measures of Sexual Attitudes and Behavior of Latino Adults

Scoring: N/A Reliability and/or validity: Please see a description of the instruments. Marín BV, Tschann J, Gómez C, Gregorich SE (1998). Self-efficacy to use condoms in unmarried Latino adults. American Journal of Community Psychology. 26(1), 53–71.

Motivators and Barriers To Use Of Combination Therapies In Patients With HIV Disease

The successful two-drug combination therapy in 1994 and protease inhibitors in 1995 set the stage for a new era in treatment of HIV disease, creating a burst of optimism over the prospect that HIV might be a controllable disease. Initial studies of protease containing triple-drug regimens suggested that these combinations could, in some cases, slow clinical progression of the disease and prolong the lives of patients.

Usuarios de drogas

A pesar del alto riesgo de transmisión del VIH al compartir jeringas, la relación que existe entre el VIH y el uso de drogas va mucho mas allá del tema de las jeringas. Las personas adictas al alcohol, al “speed” y a la cocaína-crack, los “poppers” o cualquier otra droga no inyectada, están más propensos que aquellos que no usan drogas a ser portadores del VIH y a convertirse en seropositivos.